import os
import json

def write_page(filepath, content):
    with open(filepath, "w") as f:
        f.write(content)

# Page 1: Undervalued Stocks
page1_content = """---
import SiteLayout from "../../../layouts/SiteLayout.astro";

export const meta = {
  title: "Top 10 Undervalued Stocks for April 2025: Deep Value Opportunities",
  description: "Are you missing out on the market's hidden gems? Discover the top undervalued stocks for April 2025 that Wall Street might be overlooking...",
  category: "list",
  published: "2025-03-25",
};

const schema = {
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Article",
      "headline": meta.title,
      "description": meta.description,
      "author": {
        "@type": "Organization",
        "name": "Westmount Fundamentals"
      },
      "publisher": {
        "@type": "Organization",
        "name": "Westmount Fundamentals",
        "logo": {
          "@type": "ImageObject",
          "url": "https://westmountfundamentals.com/logo.png"
        }
      },
      "datePublished": meta.published
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What are the best undervalued stocks april 2025?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The best undervalued stocks for April 2025 typically include companies with low Price-to-Earnings (P/E) ratios relative to their historical averages and sector peers. Examples often include large-cap financials, established healthcare companies, and legacy automakers that are currently out of favor with the broader market but maintain strong cash flows."
          }
        },
        {
          "@type": "Question",
          "name": "How do I identify undervalued stocks?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Identifying undervalued stocks involves fundamental analysis. Key metrics to look at include the Price-to-Earnings (P/E) ratio, Price-to-Book (P/B) ratio, Price-to-Sales (P/S) ratio, and Free Cash Flow yield. Comparing these metrics to the company's historical averages and industry competitors can highlight potential undervaluation."
          }
        },
        {
          "@type": "Question",
          "name": "Are undervalued stocks safe?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "While undervalued stocks can offer a margin of safety due to their lower valuations, they are not inherently 'safe.' Sometimes a stock is cheap for a reason, such as deteriorating fundamentals or obsolete technology, a situation known as a 'value trap.' Thorough research is essential."
          }
        },
        {
          "@type": "Question",
          "name": "When should I buy undervalued stocks?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The best time to buy undervalued stocks is often when broader market sentiment is negative or when a specific sector is temporarily out of favor due to short-term headwinds. Investors with a long-term horizon can capitalize on these pricing discrepancies before the market corrects them."
          }
        },
        {
          "@type": "Question",
          "name": "What is a value trap?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "A value trap occurs when a stock appears to be cheap based on traditional valuation metrics (like a low P/E ratio), but the company is experiencing structural decline. Investors buy the stock thinking it is a bargain, only to see the price continue to fall as the underlying business deteriorates."
          }
        }
      ]
    }
  ]
};

const stocks = [
  { symbol: "C", name: "Citigroup Inc.", sector: "Financials", pe: "14.5", pb: "0.6", yield: "3.5%" },
  { symbol: "GM", name: "General Motors Co.", sector: "Consumer Discretionary", pe: "5.8", pb: "0.8", yield: "1.2%" },
  { symbol: "PFE", name: "Pfizer Inc.", sector: "Health Care", pe: "12.3", pb: "1.7", yield: "6.1%" },
  { symbol: "CVS", name: "CVS Health Corp.", sector: "Health Care", pe: "10.1", pb: "1.2", yield: "3.8%" },
  { symbol: "VZ", name: "Verizon Communications", sector: "Communication Services", pe: "8.9", pb: "1.8", yield: "6.5%" },
  { symbol: "WBA", name: "Walgreens Boots Alliance", sector: "Consumer Staples", pe: "6.2", pb: "0.5", yield: "5.0%" },
  { symbol: "F", name: "Ford Motor Company", sector: "Consumer Discretionary", pe: "7.1", pb: "1.1", yield: "5.2%" },
  { symbol: "BMY", name: "Bristol-Myers Squibb", sector: "Health Care", pe: "13.5", pb: "2.8", yield: "4.9%" },
  { symbol: "T", name: "AT&T Inc.", sector: "Communication Services", pe: "9.2", pb: "1.3", yield: "6.6%" },
  { symbol: "KHC", name: "The Kraft Heinz Co.", sector: "Consumer Staples", pe: "11.5", pb: "0.9", yield: "4.7%" }
];
---
<SiteLayout site="westmount" title={meta.title} description={meta.description} canonical="https://westmountfundamentals.com/undervalued-stocks-april-2025" schema={schema}>
  <div class="page-content">
    <div class="hero">
      <h1>Top 10 Undervalued Stocks for April 2025</h1>
      <p class="subtitle">Discovering deep value in a momentum-driven market. Find out which companies are trading below their intrinsic value.</p>
    </div>

    <div class="article-body">
      <p>As we head into April 2025, the broader market has seen significant fluctuations, often driven by momentum in the technology and artificial intelligence sectors. However, for the discerning value investor, this creates an environment ripe with opportunity. By looking past the hype, we can identify high-quality companies that are currently trading at a discount to their intrinsic value. These are the <strong>undervalued stocks April 2025</strong> has to offer.</p>

      <p>Value investing is a strategy that involves picking stocks that appear to be trading for less than their intrinsic or book value. Investors who use this strategy believe the market overreacts to good and bad news, resulting in stock price movements that do not correspond with the company's long-term fundamentals. The result is an opportunity for value investors to profit by buying when the price is deflated. This guide explores some of the most compelling undervalued opportunities available right now, providing you with real data and actionable insights.</p>

      <h2>Why Look for Undervalued Stocks Now?</h2>
      <p>In a market where many popular stocks are priced for perfection, the margin of safety can be remarkably thin. If a high-flying growth company misses earnings estimates by even a fraction, its stock price can plummet. In contrast, undervalued stocks often have a larger margin of safety. Their stock prices already reflect negative sentiment or temporary headwinds, meaning there is less downside risk and substantial upside potential if the company's fortunes improve or if the market simply realizes its true worth.</p>

      <p>When searching for undervalued stocks, investors typically focus on a few key financial metrics. The Price-to-Earnings (P/E) ratio is perhaps the most famous, comparing a company's share price to its earnings per share. A low P/E relative to the broader market or the company's historical average can indicate undervaluation. Another critical metric is the Price-to-Book (P/B) ratio, which compares a firm's market capitalization to its book value. For sectors like financials, P/B is a vital tool. Additionally, a strong and sustainable dividend yield can be a hallmark of an undervalued, mature business that generates consistent cash flow.</p>

      <p>If you're also looking for broader market exposure rather than individual stock picking, you might want to consider the <a href="/best-etfs-for-beginners-2025">best ETFs for beginners 2025</a>, which offer diversified investments to build your portfolio foundation.</p>

      <h2>The Top 10 Undervalued Stocks for April 2025</h2>
      <p>Below is our carefully curated list of the top undervalued stocks for April 2025. This table is sortable and filterable, allowing you to analyze these companies based on the metrics that matter most to you.</p>

      <div class="search-container">
        <input type="text" id="searchInput" placeholder="Search stocks by name, symbol, or sector..." />
      </div>

      <div class="table-container">
        <table id="dataTable">
          <thead>
            <tr>
              <th onclick="sortTable(0)">Symbol &#x2195;</th>
              <th onclick="sortTable(1)">Company Name &#x2195;</th>
              <th onclick="sortTable(2)">Sector &#x2195;</th>
              <th onclick="sortTable(3)">P/E Ratio &#x2195;</th>
              <th onclick="sortTable(4)">P/B Ratio &#x2195;</th>
              <th onclick="sortTable(5)">Dividend Yield &#x2195;</th>
            </tr>
          </thead>
          <tbody>
            {stocks.map((stock) => (
              <tr>
                <td><strong>{stock.symbol}</strong></td>
                <td>{stock.name}</td>
                <td>{stock.sector}</td>
                <td>{stock.pe}</td>
                <td>{stock.pb}</td>
                <td>{stock.yield}</td>
              </tr>
            ))}
          </tbody>
        </table>
      </div>

      <h2>Detailed Analysis of Key Undervalued Stocks</h2>

      <div class="card">
        <h3>1. Citigroup Inc. (C)</h3>
        <p>Citigroup stands out as a classic value play in the financial sector. Trading significantly below its book value (P/B around 0.6), the market is pricing in a significant amount of pessimism regarding its restructuring efforts. However, if management can successfully streamline operations and improve returns on tangible common equity, there is substantial room for multiple expansion. The current dividend yield provides a solid income stream while investors wait for the turnaround to materialize.</p>
      </div>

      <div class="card">
        <h3>2. General Motors Co. (GM)</h3>
        <p>Despite strong profits and a massive share buyback program, General Motors continues to trade at a single-digit P/E ratio. The market remains skeptical about the long-term profitability of the transition to electric vehicles (EVs) and the potential for a cyclical downturn in auto sales. However, GM's legacy internal combustion engine (ICE) business is a cash cow, funding its future endeavors and rewarding shareholders in the present. At a P/E of around 5.8, the stock appears deeply undervalued.</p>
      </div>

      <div class="card">
        <h3>3. Pfizer Inc. (PFE)</h3>
        <p>Pfizer has experienced a severe hangover following the boom of its COVID-19 vaccine and therapeutics. As revenues from these products normalized, the stock price took a heavy hit. However, Pfizer remains a pharmaceutical juggernaut with a robust pipeline and significant cash reserves for acquisitions. With a dividend yield exceeding 6%, it offers an attractive proposition for income-oriented value investors willing to wait for the next wave of blockbusters.</p>
      </div>

      <div class="card">
        <h3>4. Verizon Communications (VZ)</h3>
        <p>Telecom giants have faced headwinds from high debt loads in a rising interest rate environment and intense competition. Verizon, however, generates massive free cash flow, comfortably covering its generous dividend. While growth is slow, the stock's valuation has compressed to levels that offer an attractive entry point for defensive investors. The focus here is on income and stability rather than rapid capital appreciation.</p>
      </div>

      <div class="card">
        <h3>5. CVS Health Corp. (CVS)</h3>
        <p>CVS Health has transformed from a simple retail pharmacy into a diversified healthcare conglomerate, acquiring Aetna and expanding into care delivery. The integration process and regulatory pressures have weighed on the stock, resulting in a low P/E ratio. For investors who believe in the long-term viability of their integrated healthcare model, CVS presents a compelling value opportunity at current levels.</p>
      </div>

      <p>While exploring these individual undervalued stocks can be rewarding, some investors may prefer to explore emerging sectors. If you're looking into biotechnology, you might be wondering <a href="/what-jecizer-biosciences-ltd-stocks-to-buy-now">what jecizer biosciences ltd stocks to buy now</a> or how to gain exposure to that specific segment of the market.</p>

      <p>Remember that investing in undervalued stocks requires patience. The market can take months or even years to recognize a company's true value. It's crucial to differentiate between a temporary setback and a permanent impairment of the business model. By focusing on companies with strong balance sheets, consistent cash flows, and sustainable competitive advantages, you can tilt the odds in your favor.</p>

      <p>Furthermore, diversification is key. Never put all your capital into a single undervalued stock, as even the most thorough analysis can miss unforeseen risks. Building a portfolio of several carefully selected value stocks can help mitigate individual company risk while positioning you for long-term outperformance.</p>

      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        {schema['@graph'][1].mainEntity.map((faq) => (
          <details>
            <summary>{faq.name}</summary>
            <p>{faq.acceptedAnswer.text}</p>
          </details>
        ))}
      </section>
    </div>
  </div>

  <script is:inline>
    // Search functionality
    document.getElementById('searchInput').addEventListener('keyup', function() {
      let filter = this.value.toLowerCase();
      let rows = document.querySelectorAll('#dataTable tbody tr');

      rows.forEach(row => {
        let text = row.textContent.toLowerCase();
        row.style.display = text.includes(filter) ? '' : 'none';
      });
    });

    // Sort functionality
    function sortTable(n) {
      let table = document.getElementById("dataTable");
      let rows, switching, i, x, y, shouldSwitch, dir, switchcount = 0;
      switching = true;
      dir = "asc";

      while (switching) {
        switching = false;
        rows = table.rows;

        for (i = 1; i < (rows.length - 1); i++) {
          shouldSwitch = false;
          x = rows[i].getElementsByTagName("TD")[n];
          y = rows[i + 1].getElementsByTagName("TD")[n];

          let xContent = x.innerHTML.toLowerCase().replace(/<[^>]*>?/gm, '');
          let yContent = y.innerHTML.toLowerCase().replace(/<[^>]*>?/gm, '');

          let xNum = parseFloat(xContent.replace(/[^0-9.-]+/g,""));
          let yNum = parseFloat(yContent.replace(/[^0-9.-]+/g,""));

          if (!isNaN(xNum) && !isNaN(yNum)) {
            if (dir == "asc") {
              if (xNum > yNum) { shouldSwitch = true; break; }
            } else {
              if (xNum < yNum) { shouldSwitch = true; break; }
            }
          } else {
            if (dir == "asc") {
              if (xContent > yContent) { shouldSwitch = true; break; }
            } else {
              if (xContent < yContent) { shouldSwitch = true; break; }
            }
          }
        }

        if (shouldSwitch) {
          rows[i].parentNode.insertBefore(rows[i + 1], rows[i]);
          switching = true;
          switchcount ++;
        } else {
          if (switchcount == 0 && dir == "asc") {
            dir = "desc";
            switching = true;
          }
        }
      }
    }
  </script>

  <style is:inline>
    .page-content { max-width: 900px; margin: 0 auto; padding: 2rem 1.5rem; line-height: 1.6; }
    .hero { text-align: center; padding: 3rem 0 2rem; }
    .hero h1 { font-size: 2.2rem; font-weight: 800; margin-bottom: 0.5rem; color: var(--text-primary); }
    .subtitle { color: var(--text-secondary); font-size: 1.1rem; max-width: 700px; margin: 0 auto; }
    .article-body p { margin-bottom: 1.2rem; font-size: 1.05rem; }
    .article-body h2 { margin-top: 2rem; margin-bottom: 1rem; color: var(--text-primary); }
    .card { background: var(--card-bg); border: 1px solid var(--border-color); border-radius: 12px; padding: 1.5rem; margin: 1.5rem 0; box-shadow: 0 4px 6px rgba(0,0,0,0.05); }
    .card h3 { margin-top: 0; color: #4a8fe7; }
    .search-container { margin: 1.5rem 0; }
    .search-container input { width: 100%; padding: 0.75rem 1rem; font-size: 1rem; border: 1px solid var(--border-color); border-radius: 8px; background: var(--bg-primary); color: var(--text-primary); }
    .table-container { overflow-x: auto; margin: 1.5rem 0; }
    table { width: 100%; border-collapse: collapse; min-width: 600px; }
    th { cursor: pointer; background: var(--card-bg); font-weight: 600; white-space: nowrap; user-select: none; }
    th:hover { background: #f0f4f8; }
    th, td { padding: 0.75rem 1rem; text-align: left; border-bottom: 1px solid var(--border-color); }
    .faq-section { margin-top: 3rem; }
    .faq-section details { margin: 1rem 0; padding: 1rem; background: var(--card-bg); border-radius: 8px; border: 1px solid var(--border-color); }
    .faq-section summary { font-weight: 600; cursor: pointer; font-size: 1.1rem; }
    .faq-section p { margin-top: 0.5rem; margin-bottom: 0; }
    a { color: #4a8fe7; text-decoration: none; }
    a:hover { text-decoration: underline; }
  </style>
</SiteLayout>
"""

# Page 2: Jecizer Biosciences
page2_content = """---
import SiteLayout from "../../../layouts/SiteLayout.astro";

export const meta = {
  title: "What Jecizer Biosciences Ltd Stocks to Buy Now?",
  description: "Everyone is talking about Jecizer Biosciences, but how can you invest? Discover the closest publicly traded biotech stocks capitalizing on the same revolutionary breakthroughs...",
  category: "guide",
  published: "2025-03-25",
};

const schema = {
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Article",
      "headline": meta.title,
      "description": meta.description,
      "author": {
        "@type": "Organization",
        "name": "Westmount Fundamentals"
      },
      "publisher": {
        "@type": "Organization",
        "name": "Westmount Fundamentals",
        "logo": {
          "@type": "ImageObject",
          "url": "https://westmountfundamentals.com/logo.png"
        }
      },
      "datePublished": meta.published
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What jecizer biosciences ltd stocks to buy now?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Jecizer Biosciences Ltd is currently a private or conceptual entity and does not have publicly traded stock. To gain exposure to the innovative areas Jecizer operates in (like gene editing, personalized medicine, and advanced therapeutics), investors can look at leading public biotech stocks such as CRISPR Therapeutics (CRSP), Vertex Pharmaceuticals (VRTX), or Illumina (ILMN)."
          }
        },
        {
          "@type": "Question",
          "name": "Is Jecizer Biosciences publicly traded?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No, as of the current market data, Jecizer Biosciences Ltd is not a publicly traded company on major exchanges like the NYSE or NASDAQ. It remains privately held."
          }
        },
        {
          "@type": "Question",
          "name": "How can I invest in biotech innovation similar to Jecizer?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "You can invest in publicly traded companies that operate in the same cutting-edge fields. Companies involved in CRISPR gene editing, mRNA technology, and targeted oncology therapies offer similar exposure to biotech innovation."
          }
        },
        {
          "@type": "Question",
          "name": "What are the risks of investing in biotech stocks?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Biotech stocks are highly volatile. Risks include failure in clinical trials, strict FDA regulatory hurdles, patent cliffs, and high research and development costs that may not yield marketable products."
          }
        },
        {
          "@type": "Question",
          "name": "Are there biotech ETFs available?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes, investors looking for diversified exposure to biotechnology can invest in ETFs like the iShares Biotechnology ETF (IBB) or the SPDR S&P Biotech ETF (XBI), which hold baskets of biotech companies."
          }
        }
      ]
    }
  ]
};

const stocks = [
  { symbol: "CRSP", name: "CRISPR Therapeutics", focus: "Gene Editing", marketCap: "$4.5B", pe: "null", risk: "High" },
  { symbol: "VRTX", name: "Vertex Pharmaceuticals", focus: "Cystic Fibrosis/Gene Editing", marketCap: "$110B", pe: "30.5", risk: "Medium" },
  { symbol: "ILMN", name: "Illumina, Inc.", focus: "Genomic Sequencing", marketCap: "$22B", pe: "null", risk: "Medium" },
  { symbol: "REGN", name: "Regeneron Pharmaceuticals", focus: "Monoclonal Antibodies", marketCap: "$105B", pe: "26.2", risk: "Low-Medium" },
  { symbol: "BNTX", name: "BioNTech SE", focus: "mRNA Therapeutics", marketCap: "$21B", pe: "15.4", risk: "High" },
  { symbol: "MRNA", name: "Moderna, Inc.", focus: "mRNA Therapeutics", marketCap: "$38B", pe: "null", risk: "High" },
  { symbol: "NTLA", name: "Intellia Therapeutics", focus: "In Vivo Gene Editing", marketCap: "$2.1B", pe: "null", risk: "Very High" },
  { symbol: "EXAS", name: "Exact Sciences Corp.", focus: "Cancer Diagnostics", marketCap: "$10B", pe: "null", risk: "High" },
  { symbol: "VTYX", name: "Ventyx Biosciences", focus: "Immunology", marketCap: "$300M", pe: "null", risk: "Very High" },
  { symbol: "ALNY", name: "Alnylam Pharmaceuticals", focus: "RNAi Therapeutics", marketCap: "$19B", pe: "null", risk: "High" }
];
---
<SiteLayout site="westmount" title={meta.title} description={meta.description} canonical="https://westmountfundamentals.com/what-jecizer-biosciences-ltd-stocks-to-buy-now" schema={schema}>
  <div class="page-content">
    <div class="hero">
      <h1>What Jecizer Biosciences Ltd Stocks to Buy Now?</h1>
      <p class="subtitle">Exploring the biotech revolution: If you can't buy Jecizer directly, here are the top public alternatives leading the charge in life sciences.</p>
    </div>

    <div class="article-body">
      <p>The biotechnology sector is experiencing a renaissance, driven by breakthroughs in genomics, personalized medicine, and artificial intelligence-assisted drug discovery. Recently, there has been a surge in search interest around the query: <strong>what jecizer biosciences ltd stocks to buy now</strong>. Jecizer Biosciences has captured the imagination of the public and investors alike with its reputation for revolutionizing biotechnology, blending scientific innovation with cutting-edge technologies to address pressing healthcare challenges globally.</p>

      <p>However, there is a crucial detail that eager investors must understand: <em>Jecizer Biosciences Ltd is currently a private entity and does not have publicly traded stock.</em> You cannot open your brokerage account and buy shares of Jecizer under a specific ticker symbol. But this does not mean the investment opportunity is closed to you. The excitement surrounding Jecizer is indicative of a broader trend in the biotech industry—a trend that you can capitalize on through publicly traded companies operating in the exact same groundbreaking fields.</p>

      <h2>The Jecizer Halo Effect: Investing in Biotech Innovation</h2>
      <p>When a private company like Jecizer makes headlines for innovative solutions in drug discovery, personalized medicine, and sustainable practices, it casts a "halo effect" over the entire sector. Investors realize the immense total addressable market (TAM) for these technologies and begin looking for public equities that offer similar exposure. To build a portfolio that mirrors the ambitions of Jecizer, you need to look at companies specializing in gene editing, genomic sequencing, mRNA technology, and advanced therapeutics.</p>

      <p>Investing in biotechnology is inherently risky. The path from clinical trials to FDA approval is fraught with expensive failures. A drug might show promise in Phase 1 trials only to fail spectacularly in Phase 3, wiping out billions in market capitalization. Therefore, when selecting biotech stocks, diversification and risk assessment are paramount. Some investors prefer established giants with steady revenue streams from approved drugs (like Vertex or Regeneron) to anchor their portfolio, while dedicating a smaller speculative portion to pure-play innovators (like CRISPR or Intellia).</p>

      <h2>Top Biotech Alternatives to Jecizer Biosciences</h2>
      <p>Since you cannot buy Jecizer Biosciences directly, we have compiled a list of the top publicly traded biotechnology companies that are pushing the boundaries of science in similar ways. Use the sortable table below to explore these alternatives based on their focus area, market capitalization, and risk profile. Note that in the biotech sector, a "null" P/E ratio is common for early-stage companies that are not yet profitable, as they reinvest all capital into Research & Development.</p>

      <div class="search-container">
        <input type="text" id="searchInput" placeholder="Search biotech stocks by name, symbol, or focus..." />
      </div>

      <div class="table-container">
        <table id="dataTable">
          <thead>
            <tr>
              <th onclick="sortTable(0)">Symbol &#x2195;</th>
              <th onclick="sortTable(1)">Company Name &#x2195;</th>
              <th onclick="sortTable(2)">Primary Focus &#x2195;</th>
              <th onclick="sortTable(3)">Market Cap &#x2195;</th>
              <th onclick="sortTable(4)">P/E Ratio &#x2195;</th>
              <th onclick="sortTable(5)">Risk Profile &#x2195;</th>
            </tr>
          </thead>
          <tbody>
            {stocks.map((stock) => (
              <tr>
                <td><strong>{stock.symbol}</strong></td>
                <td>{stock.name}</td>
                <td>{stock.focus}</td>
                <td>{stock.marketCap}</td>
                <td>{stock.pe}</td>
                <td>{stock.risk}</td>
              </tr>
            ))}
          </tbody>
        </table>
      </div>

      <h2>Deep Dive: Companies Leading the Biotech Charge</h2>

      <div class="card">
        <h3>1. CRISPR Therapeutics (CRSP)</h3>
        <p>If Jecizer's appeal lies in fundamental genetic alteration, CRISPR Therapeutics is the premier public option. Founded by Emmanuelle Charpentier, one of the inventors of CRISPR-Cas9 technology, the company recently received landmark FDA approval for Casgevy, a treatment for sickle cell disease. While volatile and pre-profitability on a large scale, CRISPR represents the cutting edge of gene editing.</p>
      </div>

      <div class="card">
        <h3>2. Vertex Pharmaceuticals (VRTX)</h3>
        <p>Vertex offers a lower-risk entry into biotech. The company has a virtual monopoly on treatments for the underlying causes of cystic fibrosis, generating massive, reliable cash flows. Importantly, Vertex is partnered with CRISPR Therapeutics on Casgevy, providing exposure to next-generation gene editing while maintaining a highly profitable, established business model as a safety net.</p>
      </div>

      <div class="card">
        <h3>3. Illumina, Inc. (ILMN)</h3>
        <p>Illumina is the "picks and shovels" play of the genomic revolution. Rather than developing drugs directly, Illumina manufactures the sequencing machines and consumables that allow other companies (perhaps even Jecizer) to map genomes and discover new therapies. As genomic sequencing becomes cheaper and more ubiquitous, Illumina's fundamental infrastructure role remains vital.</p>
      </div>

      <div class="card">
        <h3>4. BioNTech SE (BNTX)</h3>
        <p>Famous for partnering with Pfizer on the COVID-19 vaccine, BioNTech's true potential lies in its mRNA platform. The company is heavily reinvesting its pandemic windfall into highly personalized oncology (cancer) treatments. Their approach—using mRNA to train the patient's immune system to attack specific cancer cells—aligns perfectly with the personalized medicine narratives surrounding Jecizer.</p>
      </div>

      <p>If the high volatility of individual biotech stocks is intimidating, you might be better suited for diversified funds. Check out our guide on the <a href="/best-etfs-for-beginners-2025">best ETFs for beginners 2025</a> to see how you can invest in broader sectors or the total market with less individual company risk.</p>

      <p>Alternatively, if you are looking for companies with lower valuations across the broader market, rather than high-growth biotech, explore our list of <a href="/undervalued-stocks-april-2025">undervalued stocks April 2025</a> to find established companies trading at a discount.</p>

      <p>In conclusion, while you cannot directly answer the question of what Jecizer Biosciences Ltd stocks to buy now with a specific ticker, the spirit of the inquiry—investing in the future of healthcare—is highly actionable. By focusing on public companies that share Jecizer's innovative DNA, investors can position their portfolios to benefit from the ongoing biotech revolution.</p>

      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        {schema['@graph'][1].mainEntity.map((faq) => (
          <details>
            <summary>{faq.name}</summary>
            <p>{faq.acceptedAnswer.text}</p>
          </details>
        ))}
      </section>
    </div>
  </div>

  <script is:inline>
    // Search functionality
    document.getElementById('searchInput').addEventListener('keyup', function() {
      let filter = this.value.toLowerCase();
      let rows = document.querySelectorAll('#dataTable tbody tr');

      rows.forEach(row => {
        let text = row.textContent.toLowerCase();
        row.style.display = text.includes(filter) ? '' : 'none';
      });
    });

    // Sort functionality
    function sortTable(n) {
      let table = document.getElementById("dataTable");
      let rows, switching, i, x, y, shouldSwitch, dir, switchcount = 0;
      switching = true;
      dir = "asc";

      while (switching) {
        switching = false;
        rows = table.rows;

        for (i = 1; i < (rows.length - 1); i++) {
          shouldSwitch = false;
          x = rows[i].getElementsByTagName("TD")[n];
          y = rows[i + 1].getElementsByTagName("TD")[n];

          let xContent = x.innerHTML.toLowerCase().replace(/<[^>]*>?/gm, '');
          let yContent = y.innerHTML.toLowerCase().replace(/<[^>]*>?/gm, '');

          let xNum = parseFloat(xContent.replace(/[^0-9.-]+/g,""));
          let yNum = parseFloat(yContent.replace(/[^0-9.-]+/g,""));

          if (!isNaN(xNum) && !isNaN(yNum)) {
            if (dir == "asc") {
              if (xNum > yNum) { shouldSwitch = true; break; }
            } else {
              if (xNum < yNum) { shouldSwitch = true; break; }
            }
          } else {
            if (dir == "asc") {
              if (xContent > yContent) { shouldSwitch = true; break; }
            } else {
              if (xContent < yContent) { shouldSwitch = true; break; }
            }
          }
        }

        if (shouldSwitch) {
          rows[i].parentNode.insertBefore(rows[i + 1], rows[i]);
          switching = true;
          switchcount ++;
        } else {
          if (switchcount == 0 && dir == "asc") {
            dir = "desc";
            switching = true;
          }
        }
      }
    }
  </script>

  <style is:inline>
    .page-content { max-width: 900px; margin: 0 auto; padding: 2rem 1.5rem; line-height: 1.6; }
    .hero { text-align: center; padding: 3rem 0 2rem; }
    .hero h1 { font-size: 2.2rem; font-weight: 800; margin-bottom: 0.5rem; color: var(--text-primary); }
    .subtitle { color: var(--text-secondary); font-size: 1.1rem; max-width: 700px; margin: 0 auto; }
    .article-body p { margin-bottom: 1.2rem; font-size: 1.05rem; }
    .article-body h2 { margin-top: 2rem; margin-bottom: 1rem; color: var(--text-primary); }
    .card { background: var(--card-bg); border: 1px solid var(--border-color); border-radius: 12px; padding: 1.5rem; margin: 1.5rem 0; box-shadow: 0 4px 6px rgba(0,0,0,0.05); }
    .card h3 { margin-top: 0; color: #4a8fe7; }
    .search-container { margin: 1.5rem 0; }
    .search-container input { width: 100%; padding: 0.75rem 1rem; font-size: 1rem; border: 1px solid var(--border-color); border-radius: 8px; background: var(--bg-primary); color: var(--text-primary); }
    .table-container { overflow-x: auto; margin: 1.5rem 0; }
    table { width: 100%; border-collapse: collapse; min-width: 600px; }
    th { cursor: pointer; background: var(--card-bg); font-weight: 600; white-space: nowrap; user-select: none; }
    th:hover { background: #f0f4f8; }
    th, td { padding: 0.75rem 1rem; text-align: left; border-bottom: 1px solid var(--border-color); }
    .faq-section { margin-top: 3rem; }
    .faq-section details { margin: 1rem 0; padding: 1rem; background: var(--card-bg); border-radius: 8px; border: 1px solid var(--border-color); }
    .faq-section summary { font-weight: 600; cursor: pointer; font-size: 1.1rem; }
    .faq-section p { margin-top: 0.5rem; margin-bottom: 0; }
    a { color: #4a8fe7; text-decoration: none; }
    a:hover { text-decoration: underline; }
  </style>
</SiteLayout>
"""

# Page 3: Best ETFs for Beginners
page3_content = """---
import SiteLayout from "../../../layouts/SiteLayout.astro";

export const meta = {
  title: "Best ETFs for Beginners 2025 & 2026: The Ultimate Starter Portfolio",
  description: "Stop trying to pick individual stocks. Discover the best ETFs for beginners 2025 that offer instant diversification and low fees to grow your wealth on autopilot...",
  category: "guide",
  published: "2025-03-25",
};

const schema = {
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Article",
      "headline": meta.title,
      "description": meta.description,
      "author": {
        "@type": "Organization",
        "name": "Westmount Fundamentals"
      },
      "publisher": {
        "@type": "Organization",
        "name": "Westmount Fundamentals",
        "logo": {
          "@type": "ImageObject",
          "url": "https://westmountfundamentals.com/logo.png"
        }
      },
      "datePublished": meta.published
    },
    {
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What are the best etfs for beginners 2025?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The best ETFs for beginners in 2025 include broad market index funds with very low expense ratios. Top recommendations include the Vanguard S&P 500 ETF (VOO), Vanguard Total Stock Market ETF (VTI), and Invesco QQQ Trust (QQQ) for tech exposure."
          }
        },
        {
          "@type": "Question",
          "name": "What are the best etfs for beginners?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The best ETFs for beginners are typically S&P 500 index funds or total stock market funds. They provide instant diversification across hundreds of companies, reducing the risk compared to picking individual stocks. Examples include VOO, SPY, and IVV."
          }
        },
        {
          "@type": "Question",
          "name": "What are the best etfs for beginners 2026?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Looking ahead to 2026, the foundational ETFs for beginners remain the same: low-cost, broadly diversified index funds like VTI (Total US Market), VXUS (Total International Market), and BND (Total Bond Market) to build a robust three-fund portfolio."
          }
        },
        {
          "@type": "Question",
          "name": "How many ETFs should a beginner own?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "A beginner can build a complete, well-diversified portfolio with just 1 to 3 ETFs. A single all-world ETF (like VT) is sufficient, or a 'three-fund portfolio' consisting of a US stock ETF, an International stock ETF, and a Bond ETF."
          }
        },
        {
          "@type": "Question",
          "name": "What is an expense ratio in an ETF?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "The expense ratio is the annual fee charged by the ETF provider to manage the fund. It is expressed as a percentage of your investment. For beginners, it's crucial to choose ETFs with low expense ratios (ideally under 0.10%) to maximize long-term returns."
          }
        }
      ]
    }
  ]
};

const etfs = [
  { symbol: "VOO", name: "Vanguard S&P 500 ETF", category: "Large Cap Blend", expenseRatio: "0.03%", aum: "$420B", yield: "1.35%" },
  { symbol: "VTI", name: "Vanguard Total Stock Market ETF", category: "Total US Market", expenseRatio: "0.03%", aum: "$380B", yield: "1.38%" },
  { symbol: "QQQ", name: "Invesco QQQ Trust", category: "Large Growth / Tech", expenseRatio: "0.20%", aum: "$255B", yield: "0.58%" },
  { symbol: "SCHD", name: "Schwab US Dividend Equity ETF", category: "Large Value / Dividend", expenseRatio: "0.06%", aum: "$55B", yield: "3.42%" },
  { symbol: "VXUS", name: "Vanguard Total International Stock", category: "International Equity", expenseRatio: "0.08%", aum: "$68B", yield: "3.10%" },
  { symbol: "BND", name: "Vanguard Total Bond Market ETF", category: "US Core Bond", expenseRatio: "0.03%", aum: "$105B", yield: "3.25%" },
  { symbol: "VT", name: "Vanguard Total World Stock ETF", category: "Global Equity", expenseRatio: "0.07%", aum: "$42B", yield: "2.05%" },
  { symbol: "VUG", name: "Vanguard Growth ETF", category: "Large Growth", expenseRatio: "0.04%", aum: "$115B", yield: "0.50%" },
  { symbol: "VTV", name: "Vanguard Value ETF", category: "Large Value", expenseRatio: "0.04%", aum: "$110B", yield: "2.45%" },
  { symbol: "RSP", name: "Invesco S&P 500 Equal Weight ETF", category: "Large Cap Blend (Equal)", expenseRatio: "0.20%", aum: "$50B", yield: "1.55%" }
];
---
<SiteLayout site="westmount" title={meta.title} description={meta.description} canonical="https://westmountfundamentals.com/best-etfs-for-beginners-2025" schema={schema}>
  <div class="page-content">
    <div class="hero">
      <h1>The Best ETFs for Beginners in 2025 & 2026</h1>
      <p class="subtitle">Build lasting wealth without the stress of stock picking. Here are the foundational exchange-traded funds every new investor needs.</p>
    </div>

    <div class="article-body">
      <p>Starting your investing journey can feel overwhelming. With thousands of stocks to choose from, market volatility, and complex financial jargon, it's easy to succumb to 'analysis paralysis'. The solution? Exchange-Traded Funds (ETFs). Searching for the <strong>best etfs for beginners 2025</strong> is the smartest first step you can take. ETFs allow you to buy a basket of hundreds or thousands of stocks in a single transaction, providing instant diversification and significantly reducing risk.</p>

      <p>Whether you are looking for the <strong>best etfs for beginners</strong> right now or planning ahead for the <strong>best etfs for beginners 2026</strong>, the fundamental principles of sound investing remain unchanged: keep your costs low, diversify broadly, and hold for the long term. This guide will break down the top ETFs that should form the core of any novice investor's portfolio.</p>

      <h2>Why ETFs are the Ultimate Beginner Investment</h2>
      <p>An ETF is a type of pooled investment security that operates much like a mutual fund. However, unlike mutual funds, ETFs can be bought and sold on a stock exchange the same way that a regular stock can. This means you can trade them throughout the day at fluctuating prices.</p>

      <p>For beginners, ETFs offer three massive advantages:</p>
      <ul>
        <li><strong>Instant Diversification:</strong> Buying one share of an S&P 500 ETF means you own a tiny piece of the 500 largest US companies. If one company fails, your portfolio won't be devastated.</li>
        <li><strong>Low Costs:</strong> Passively managed ETFs (which track an index rather than having a manager pick stocks) have incredibly low "expense ratios" (annual fees). Keeping fees low is critical to long-term compounding.</li>
        <li><strong>Simplicity:</strong> You don't need to read balance sheets, listen to earnings calls, or predict market trends. You simply buy the broader market and let capitalism do the rest.</li>
      </ul>

      <p>If you prefer to dig into individual companies, you can complement your ETF strategy with a few carefully chosen <a href="/undervalued-stocks-april-2025">undervalued stocks April 2025</a>. However, individual stocks should typically make up a smaller, satellite portion of a beginner's portfolio.</p>

      <h2>Top 10 Best ETFs for Beginners</h2>
      <p>Below is a curated list of the most robust, low-cost, and reliable ETFs available. This list includes everything you need to build a comprehensive portfolio, from US large-caps to international stocks and bonds. Use the search and sort functions to compare their expense ratios and yields.</p>

      <div class="search-container">
        <input type="text" id="searchInput" placeholder="Search ETFs by name, symbol, or category..." />
      </div>

      <div class="table-container">
        <table id="dataTable">
          <thead>
            <tr>
              <th onclick="sortTable(0)">Symbol &#x2195;</th>
              <th onclick="sortTable(1)">Fund Name &#x2195;</th>
              <th onclick="sortTable(2)">Category &#x2195;</th>
              <th onclick="sortTable(3)">Expense Ratio &#x2195;</th>
              <th onclick="sortTable(4)">Assets (AUM) &#x2195;</th>
              <th onclick="sortTable(5)">Div Yield &#x2195;</th>
            </tr>
          </thead>
          <tbody>
            {etfs.map((etf) => (
              <tr>
                <td><strong>{etf.symbol}</strong></td>
                <td>{etf.name}</td>
                <td>{etf.category}</td>
                <td>{etf.expenseRatio}</td>
                <td>{etf.aum}</td>
                <td>{etf.yield}</td>
              </tr>
            ))}
          </tbody>
        </table>
      </div>

      <h2>Building Your Beginner Portfolio: The Core Funds</h2>

      <div class="card">
        <h3>1. Vanguard S&P 500 ETF (VOO) or Total Market (VTI)</h3>
        <p>This is the cornerstone of almost every successful beginner portfolio. VOO tracks the S&P 500 (the 500 largest US companies), while VTI tracks the entire US stock market (including mid and small-cap companies). Both are phenomenal choices with incredibly low expense ratios of 0.03%. If you only ever buy one ETF in your life, make it one of these.</p>
      </div>

      <div class="card">
        <h3>2. Vanguard Total International Stock ETF (VXUS)</h3>
        <p>While the US market has dominated over the past decade, historical cycles show that international markets frequently outperform the US. To protect against geographic risk, adding VXUS gives you exposure to developed and emerging markets outside the United States. A common allocation is 70% VTI / 30% VXUS.</p>
      </div>

      <div class="card">
        <h3>3. Invesco QQQ Trust (QQQ)</h3>
        <p>For investors with a higher risk tolerance who want greater exposure to the technology sector, QQQ is the gold standard. It tracks the Nasdaq-100 index, which is heavily weighted towards tech giants like Apple, Microsoft, Amazon, and emerging AI leaders. While it offers higher growth potential, it also comes with higher volatility than a standard S&P 500 fund.</p>
      </div>

      <div class="card">
        <h3>4. Schwab US Dividend Equity ETF (SCHD)</h3>
        <p>If your goal is to generate passive income or if you prefer the stability of mature, cash-flowing companies, SCHD is highly recommended. It tracks an index of companies with a history of consistently paying and growing their dividends. It tends to be less volatile during market downturns than growth-focused funds.</p>
      </div>

      <p>Are you curious about high-growth, speculative sectors like biotechnology? While there might be buzz around questions like <a href="/what-jecizer-biosciences-ltd-stocks-to-buy-now">what jecizer biosciences ltd stocks to buy now</a>, beginners are often better served by broad market ETFs before venturing into volatile individual biotech stocks.</p>

      <h2>The "Three-Fund Portfolio" Strategy</h2>
      <p>The simplest and most effective strategy for beginners is the "Boglehead" Three-Fund Portfolio. This consists of:</p>
      <ol>
        <li>A Total US Stock Market ETF (e.g., VTI)</li>
        <li>A Total International Stock ETF (e.g., VXUS)</li>
        <li>A Total US Bond Market ETF (e.g., BND)</li>
      </ol>
      <p>Your age and risk tolerance dictate the percentages. A young investor in their 20s might hold 0% to 10% in bonds (BND), while someone nearing retirement might hold 40% or more. This simple strategy has historically outperformed the vast majority of highly-paid, professional active mutual fund managers over a 20-year timeline.</p>

      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        {schema['@graph'][1].mainEntity.map((faq) => (
          <details>
            <summary>{faq.name}</summary>
            <p>{faq.acceptedAnswer.text}</p>
          </details>
        ))}
      </section>
    </div>
  </div>

  <script is:inline>
    // Search functionality
    document.getElementById('searchInput').addEventListener('keyup', function() {
      let filter = this.value.toLowerCase();
      let rows = document.querySelectorAll('#dataTable tbody tr');

      rows.forEach(row => {
        let text = row.textContent.toLowerCase();
        row.style.display = text.includes(filter) ? '' : 'none';
      });
    });

    // Sort functionality
    function sortTable(n) {
      let table = document.getElementById("dataTable");
      let rows, switching, i, x, y, shouldSwitch, dir, switchcount = 0;
      switching = true;
      dir = "asc";

      while (switching) {
        switching = false;
        rows = table.rows;

        for (i = 1; i < (rows.length - 1); i++) {
          shouldSwitch = false;
          x = rows[i].getElementsByTagName("TD")[n];
          y = rows[i + 1].getElementsByTagName("TD")[n];

          let xContent = x.innerHTML.toLowerCase().replace(/<[^>]*>?/gm, '');
          let yContent = y.innerHTML.toLowerCase().replace(/<[^>]*>?/gm, '');

          let xNum = parseFloat(xContent.replace(/[^0-9.-]+/g,""));
          let yNum = parseFloat(yContent.replace(/[^0-9.-]+/g,""));

          if (!isNaN(xNum) && !isNaN(yNum)) {
            if (dir == "asc") {
              if (xNum > yNum) { shouldSwitch = true; break; }
            } else {
              if (xNum < yNum) { shouldSwitch = true; break; }
            }
          } else {
            if (dir == "asc") {
              if (xContent > yContent) { shouldSwitch = true; break; }
            } else {
              if (xContent < yContent) { shouldSwitch = true; break; }
            }
          }
        }

        if (shouldSwitch) {
          rows[i].parentNode.insertBefore(rows[i + 1], rows[i]);
          switching = true;
          switchcount ++;
        } else {
          if (switchcount == 0 && dir == "asc") {
            dir = "desc";
            switching = true;
          }
        }
      }
    }
  </script>

  <style is:inline>
    .page-content { max-width: 900px; margin: 0 auto; padding: 2rem 1.5rem; line-height: 1.6; }
    .hero { text-align: center; padding: 3rem 0 2rem; }
    .hero h1 { font-size: 2.2rem; font-weight: 800; margin-bottom: 0.5rem; color: var(--text-primary); }
    .subtitle { color: var(--text-secondary); font-size: 1.1rem; max-width: 700px; margin: 0 auto; }
    .article-body p { margin-bottom: 1.2rem; font-size: 1.05rem; }
    .article-body h2 { margin-top: 2rem; margin-bottom: 1rem; color: var(--text-primary); }
    .article-body ul, .article-body ol { margin-bottom: 1.2rem; padding-left: 1.5rem; }
    .article-body li { margin-bottom: 0.5rem; }
    .card { background: var(--card-bg); border: 1px solid var(--border-color); border-radius: 12px; padding: 1.5rem; margin: 1.5rem 0; box-shadow: 0 4px 6px rgba(0,0,0,0.05); }
    .card h3 { margin-top: 0; color: #4a8fe7; }
    .search-container { margin: 1.5rem 0; }
    .search-container input { width: 100%; padding: 0.75rem 1rem; font-size: 1rem; border: 1px solid var(--border-color); border-radius: 8px; background: var(--bg-primary); color: var(--text-primary); }
    .table-container { overflow-x: auto; margin: 1.5rem 0; }
    table { width: 100%; border-collapse: collapse; min-width: 600px; }
    th { cursor: pointer; background: var(--card-bg); font-weight: 600; white-space: nowrap; user-select: none; }
    th:hover { background: #f0f4f8; }
    th, td { padding: 0.75rem 1rem; text-align: left; border-bottom: 1px solid var(--border-color); }
    .faq-section { margin-top: 3rem; }
    .faq-section details { margin: 1rem 0; padding: 1rem; background: var(--card-bg); border-radius: 8px; border: 1px solid var(--border-color); }
    .faq-section summary { font-weight: 600; cursor: pointer; font-size: 1.1rem; }
    .faq-section p { margin-top: 0.5rem; margin-bottom: 0; }
    a { color: #4a8fe7; text-decoration: none; }
    a:hover { text-decoration: underline; }
  </style>
</SiteLayout>
"""

write_page("src/pages/sites/westmount/undervalued-stocks-april-2025.astro", page1_content)
write_page("src/pages/sites/westmount/what-jecizer-biosciences-ltd-stocks-to-buy-now.astro", page2_content)
write_page("src/pages/sites/westmount/best-etfs-for-beginners-2025.astro", page3_content)
